RecallRadar

FDA Drug recall D-0037-2016

Sunmark loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a) 10-count tablets per box (NDC 49348-930-01, UPC 0 1093936544 6)

On 2015-10-21 the FDA classified a Class III recall of Sunmark loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a) 10-count tablets per box (NDC 49348-930-01, UPC 0 1093936544 6) by Ohm Laboratories, citing superpotent Drug: Out Of Specification (OOS) result for Assay.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0037-2016
ClassificationClass III
Statusterminated
Initiated2015-07-28
Published2015-10-21
Last updated2026-09-13 11:51 UTC
CompanyOhm Laboratories
DistributionUS

Product

Sunmark loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a) 10-count tablets per box (NDC 49348-930-01, UPC 0 1093936544 6); and b) 30-count tablets per box (NDC 49348-930-44, UPC 0 1093934944 6) Distributed by McKesson, One Post Street, San Francisco, CA 94104

Reason

Superpotent Drug: Out Of Specification (OOS) result for Assay.

Identifiers

upc010939365446
upc010939349446
code_infoBatch Numbers: (a) 2544488, Exp 7/31/2016; 26917891, Exp 5/31/2016. (b) 2544488, Exp 7/31/2016; 2617893, Exp 5/31/2016; 2644273, Exp 9/30/2016

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0037-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.